Side by side

Compare compounds

Add up to three compounds with the compare button on any library card or compound page.

Swipe the table sideways to see every compound.

Attribute	Pramlintide Get updates
Category	Metabolic
Evidence grade	A Human trial evidence
Regulatory status	Approved, no longer marketed
Human amounts	FDA labelDosing reference Study durations
Format
Type	Single compound
Molecular formula	C₁₇₁H₂₆₇N₅₁O₅₃S₂
Molecular weight	3,949.4 g/mol
CAS number	151126-32-8
Sequence	Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
References	6
Summary	Pramlintide is a synthetic 37-amino-acid analog of human amylin, FDA-approved in 2005 as Symlin for adjunctive use with mealtime insulin in type 1 and type 2 diabetes; Drugs@FDA now lists all Symlin products as discontinued.